Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Tocilizumab in Multiple Myeloma: NCT07609940 Clinical Landscape Report 2026
16 September 2026
NCT07609940 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MK-4884 in Solid tumor: NCT07600749 Clinical Landscape Report 2026
16 September 2026
NCT07600749 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ocrelizumab biosimilar(Polpharma Biologics) in Multiple Sclerosis, Primary Progressive: NCT07606521 Clinical Landscape Report 2026
16 September 2026
NCT07606521 clinical landscape for Multiple Sclerosis, Primary Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
Rocbrutinib in Mantle-Cell Lymphoma: NCT07609862 Clinical Landscape Report 2026
16 September 2026
NCT07609862 clinical landscape for Mantle-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ocrelizumab in Multiple Sclerosis: NCT07609719 Clinical Landscape Report 2026
16 September 2026
NCT07609719 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Belantamab mafodotin in Hepatic Insufficiency: NCT07609706 Clinical Landscape Report 2026
16 September 2026
NCT07609706 clinical landscape for Hepatic Insufficiency: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pemetrexed Dipotassium in Large B-cell lymphoma: NCT07608731 Clinical Landscape Report 2026
16 September 2026
NCT07608731 clinical landscape for Large B-cell lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ABBV-519 in Rheumatoid Arthritis: NCT07607964 Clinical Landscape Report 2026
16 September 2026
NCT07607964 clinical landscape for Rheumatoid Arthritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voclosporin in Lupus Nephritis: NCT07611214 Clinical Landscape Report 2026
16 September 2026
NCT07611214 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Advanced Renal Cell Carcinoma: NCT07611825 Clinical Landscape Report 2026
16 September 2026
NCT07611825 clinical landscape for Advanced Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ALK.CAR-T cells(University of Turin/Boston Children) in Relapse multiple myeloma: NCT07611149 Clinical Landscape Report 2026
16 September 2026
NCT07611149 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
INV-8989 in Locally Advanced Malignant Solid Neoplasm: NCT07610798 Clinical Landscape Report 2026
16 September 2026
NCT07610798 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…